Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Aug;71(8):5997–6002. doi: 10.1128/jvi.71.8.5997-6002.1997

Hepatitis C virus envelope proteins bind lactoferrin.

M Yi 1, S Kaneko 1, D Y Yu 1, S Murakami 1
PMCID: PMC191856  PMID: 9223490

Abstract

Hepatitis C virus (HCV) has two envelope proteins, E1 and E2, which form a heterooligomer. During dissection of interacting regions of HCV E1 and E2, we found the presence of an interfering compound or compounds in skim milk. Here we report that human as well as bovine lactoferrin, a multifunctional immunomodulator, binds two HCV envelope proteins. As determined by far-Western blotting, the bacterially expressed E1 and E2 could bind lactoferrin in human milk directly separated or immunopurified and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The bindings of lactoferrin and HCV envelope proteins in vitro were confirmed by another method, the pull-down assay, with immunoprecipitated lactoferrin-bound protein A resin. By the same assay, mammal-expressed recombinant E1 and E2 were also demonstrated to bind human lactoferrin efficiently in vitro. Direct interaction between E2 and lactoferrin was proved in vivo, since anti-human lactoferrin antibody efficiently coimmunoprecipitated with secreted and intracellular forms of the E2 protein, but not glutathione S-transferase (GST), from lysates of HepG2 cells transiently cotransfected with the expression plasmids of human lactoferrin and gE2t-GST (the N-terminal two-thirds of E2 fused to GST) or GST. The N-terminal loop of lactoferrin, the region important for the antibacterial activity, has only a little role in the binding ability to HCV E2 but affected the secretion or stability of lactoferrin. Taken together, these results indicate the specific interaction between lactoferrin and HCV envelope proteins in vivo and in vitro.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhandari B. N., Wright T. L. Hepatitis C: an overview. Annu Rev Med. 1995;46:309–317. doi: 10.1146/annurev.med.46.1.309. [DOI] [PubMed] [Google Scholar]
  2. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today. 1995 Sep;16(9):417–419. doi: 10.1016/0167-5699(95)80016-6. [DOI] [PubMed] [Google Scholar]
  3. Defer M. C., Dugas B., Picard O., Damais C. Impairment of circulating lactoferrin in HIV-1 infection. Cell Mol Biol (Noisy-le-grand) 1995 May;41(3):417–421. [PubMed] [Google Scholar]
  4. Dubuisson J., Hsu H. H., Cheung R. C., Greenberg H. B., Russell D. G., Rice C. M. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol. 1994 Oct;68(10):6147–6160. doi: 10.1128/jvi.68.10.6147-6160.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C., Montreuil J., Spik G. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J. 1995 Dec 15;312(Pt 3):839–845. doi: 10.1042/bj3120839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fujihara T., Hayashi K. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch Virol. 1995;140(8):1469–1472. doi: 10.1007/BF01322673. [DOI] [PubMed] [Google Scholar]
  7. Grakoui A., Wychowski C., Lin C., Feinstone S. M., Rice C. M. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol. 1993 Mar;67(3):1385–1395. doi: 10.1128/jvi.67.3.1385-1395.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harmsen M. C., Swart P. J., de Béthune M. P., Pauwels R., De Clercq E., The T. H., Meijer D. K. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis. 1995 Aug;172(2):380–388. doi: 10.1093/infdis/172.2.380. [DOI] [PubMed] [Google Scholar]
  9. He J., Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature. 1995 Feb 23;373(6516):721–724. doi: 10.1038/373721a0. [DOI] [PubMed] [Google Scholar]
  10. Kaelin W. G., Jr, Krek W., Sellers W. R., DeCaprio J. A., Ajchenbaum F., Fuchs C. S., Chittenden T., Li Y., Farnham P. J., Blanar M. A. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 1992 Jul 24;70(2):351–364. doi: 10.1016/0092-8674(92)90108-o. [DOI] [PubMed] [Google Scholar]
  11. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 1993 Jul;67(7):3923–3930. doi: 10.1128/jvi.67.7.3923-3930.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kim H. H., Jimenez-Flores R. Comparison of milk proteins using preparative isoelectric focusing followed by polyacrylamide gel electrophoresis. J Dairy Sci. 1994 Aug;77(8):2177–2190. doi: 10.3168/jds.S0022-0302(94)77160-5. [DOI] [PubMed] [Google Scholar]
  13. Kojima M., Osuga T., Tsuda F., Tanaka T., Okamoto H. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Virology. 1994 Nov 1;204(2):665–672. doi: 10.1006/viro.1994.1582. [DOI] [PubMed] [Google Scholar]
  14. Lanford R. E., Notvall L., Chavez D., White R., Frenzel G., Simonsen C., Kim J. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology. 1993 Nov;197(1):225–235. doi: 10.1006/viro.1993.1583. [DOI] [PubMed] [Google Scholar]
  15. Legrand D., Mazurier J., Elass A., Rochard E., Vergoten G., Maes P., Montreuil J., Spik G. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin. Biochemistry. 1992 Sep 29;31(38):9243–9251. doi: 10.1021/bi00153a018. [DOI] [PubMed] [Google Scholar]
  16. Levay P. F., Viljoen M. Lactoferrin: a general review. Haematologica. 1995 May-Jun;80(3):252–267. [PubMed] [Google Scholar]
  17. Lin H. H., Kao J. H., Hsu H. Y., Ni Y. H., Yeh S. H., Hwang L. H., Chang M. H., Hwang S. C., Chen P. J., Chen D. S. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis. 1994 Mar;169(3):638–641. doi: 10.1093/infdis/169.3.638. [DOI] [PubMed] [Google Scholar]
  18. Lönnerdal B., Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr. 1995;15:93–110. doi: 10.1146/annurev.nu.15.070195.000521. [DOI] [PubMed] [Google Scholar]
  19. Matsuura Y., Suzuki T., Suzuki R., Sato M., Aizaki H., Saito I., Miyamura T. Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology. 1994 Nov 15;205(1):141–150. doi: 10.1006/viro.1994.1629. [DOI] [PubMed] [Google Scholar]
  20. McAbee D. D. Isolated rat hepatocytes acquire iron from lactoferrin by endocytosis. Biochem J. 1995 Oct 15;311(Pt 2):603–609. doi: 10.1042/bj3110603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Murakami S., Cheong J. H., Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem. 1994 May 27;269(21):15118–15123. [PubMed] [Google Scholar]
  22. Okada S., Akahane Y., Suzuki H., Okamoto H., Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology. 1992 Sep;16(3):619–624. doi: 10.1002/hep.1840160302. [DOI] [PubMed] [Google Scholar]
  23. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q. L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol. 1993 Nov;67(11):6753–6761. doi: 10.1128/jvi.67.11.6753-6761.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Selby M. J., Glazer E., Masiarz F., Houghton M. Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology. 1994 Oct;204(1):114–122. doi: 10.1006/viro.1994.1515. [DOI] [PubMed] [Google Scholar]
  25. Tibbs C. J. Methods of transmission of hepatitis C. J Viral Hepat. 1995;2(3):113–119. doi: 10.1111/j.1365-2893.1995.tb00016.x. [DOI] [PubMed] [Google Scholar]
  26. Weiner A. J., Geysen H. M., Christopherson C., Hall J. E., Mason T. J., Saracco G., Bonino F., Crawford K., Marion C. D., Crawford K. A. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3468–3472. doi: 10.1073/pnas.89.8.3468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wejstål R., Widell A., Månsson A. S., Hermodsson S., Norkrans G. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med. 1992 Dec 1;117(11):887–890. doi: 10.7326/0003-4819-117-11-887. [DOI] [PubMed] [Google Scholar]
  28. Wu H. F., Monroe D. M., Church F. C. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch Biochem Biophys. 1995 Feb 20;317(1):85–92. doi: 10.1006/abbi.1995.1139. [DOI] [PubMed] [Google Scholar]
  29. Yi M., Nakamoto Y., Kaneko S., Yamashita T., Murakami S. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2. Virology. 1997 Apr 28;231(1):119–129. doi: 10.1006/viro.1997.8516. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES